Psyence Biomedical's Texas Subsidiary Secures Exclusive U.S. Ibogaine Hydrochloride License

On September 28, 2026, Psyence Biomedical Ltd. filed a Form 6-K with the SEC revealing that its wholly owned Texas subsidiary, Texas Ibogaine.